Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...
Section 3 provides detailed guidance on the level of information that should be provided in the evidence submission template about the cost effectiveness of the appraised technology. When completing ...
This module provides an introduction to mathematical modelling and its role in informing clinical policy and resource allocation decisions in international healthcare systems. The core of the module ...
This course is compulsory on the Executive MSc in Health Economics and Policy (LSE and Chicago). This course is not available as an outside option. This course will introduce students to the basic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback